Fattaey Ali Ph.D.

Avg. Two Year Performance

(20%) Avg. Purchase Return
(9%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(16%)(22%)45%9%(20%)
Purchase Success Rate1 of 31 of 31 of 31 of 32 of 3
Average Sale Return----------
Sale Success Rate----------
Drugs » Biotechnology

President & CEO, Director:

Holdings: 322.14K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--